Nasser Shatha, Makhdoom Tazeen, Alhubaishi Laila Yahya Ahmad, Elbiss Hassan M
Shatha Nasser, MBBS. Department of Obstetrics and Gynecology, Latifa Hospital, Dubai, United Arab Emirates.
Tazeen Makhdoom, MBBS. Department of Obstetrics and Gynecology Latifa Hospital, Dubai, United Arab Emirates.
Pak J Med Sci. 2024 Aug;40(7):1425-1429. doi: 10.12669/pjms.40.7.8751.
BACKGROUND & OBJECTIVE: Miscarriage, a common complication of early pregnancy before 12 completed weeks of gestation, is typically managed medically. We aimed to estimate the success and complication rate of medical management in women with first-trimester missed miscarriages. Our objective was to calculate the rate of complete uterine evacuation within three weeks of treatment, rate of infection, significant blood loss, re-admission, or surgical evacuation.
It was a retrospective cross-sectional study that included women diagnosed with miscarriage at less than 13 weeks' gestation in Latifa Hospital's Gynecology Department from January 2019 to December 2019 in Dubai. These patients were given vaginal misoprostol, 400-800 mcg every 6-8 hours until expulsion of pregnancy.
There were 294 women included in the study. The success rate was 60.5% (178/294). Twenty women developed significant blood loss (6.8%), four women developed infection (1.4%), 76 required readmission (25.9%), 12 women received blood transfusion (4.1%), and 74 women required a surgical evacuation (25.2%). Nulliparity, unscarred uterus, and the presence of abdominal pain with vaginal bleeding before treatment were significantly associated with the successful medical treatment (p<0.05).
The success rate of the medical regimen studied lies on the lower end of what is quoted in the literature. The difference in the success rate could be attributed to the different definitions of success in other studies. Nulliparity, unscarred uterus and presence of abdominal pain with vaginal bleeding were associated with higher success.
流产是妊娠12周之前早期妊娠常见的并发症,通常采用药物治疗。我们旨在评估孕早期稽留流产女性药物治疗的成功率和并发症发生率。我们的目标是计算治疗后三周内完全清宫率、感染率、严重失血率、再次入院率或手术清宫率。
这是一项回顾性横断面研究,纳入了2019年1月至2019年12月在迪拜拉提法医院妇科诊断为妊娠小于13周流产的女性。这些患者每6 - 8小时阴道给予米索前列醇400 - 800微克,直至妊娠物排出。
本研究共纳入294名女性。成功率为60.5%(178/294)。20名女性出现严重失血(6.8%),4名女性发生感染(1.4%),76名女性需要再次入院(25.9%),12名女性接受输血(4.1%),74名女性需要手术清宫(25.2%)。未生育、子宫无瘢痕以及治疗前伴有腹痛和阴道出血与药物治疗成功显著相关(p<0.05)。
本研究的药物治疗方案成功率处于文献报道的较低水平。成功率的差异可能归因于其他研究中成功的定义不同。未生育、子宫无瘢痕以及伴有腹痛和阴道出血与较高的成功率相关。